QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BBNX

QT56Beta Bionics, Inc.
NASDAQ·Healthcare·Medical - Equipment & Services·USA
Latest market price
13.88
+0.69+5.23%
OverviewShort InterestFilings
BBNXQT56Beta Bionics, Inc.·NASDAQ
OverviewShort InterestFilings
13.88+5.23%
TA
Loading chart...
Screen all →
HIMS+11.23%$35.47NVST+4.22%$25.91CON+0.63%$28.56
Snapshot
Index-P/E-EPS (ttm)-1.51Insider Own2.94%Shs Outstand44.56MPerf Week
-5.51%
Market Cap587.77MForward P/E-EPS next Y-2.14Insider Trans-0.10%Shs Float-Perf Month47.35%
Enterprise Value564.47MPEG-EPS next Q-0.62Inst Own-Short Float-Perf Quarter28.52%
Income-66652977.00P/S5.33EPS this Y-44.17%Inst Trans-Short Ratio-Perf Half Y-53.16%
Sales110.24MP/B2.16EPS next Y1.84%ROA-21.82%Short Interest-Perf YTD-54.45%
Book/sh6.08P/C-EPS next 5Y-ROE-23.00%52W High32.71 -57.57%Perf Year-23.86%
Cash/sh4.49P/FCF-EPS past 3/5Y-ROIC-27.31%52W Low8.80 57.73%Perf 3Y-
Dividend Est.-EV/EBITDA-8.89Sales past 3/5Y-Gross Margin57.15%Volatility5.15% 5.07%Perf 5Y-
Dividend TTM-EV/Sales5.12EPS Y/Y TTM82.44%Oper. Margin-70.13%ATR (14)0.92Perf 10Y-
Dividend Ex-Date-Quick Ratio9.67Sales Y/Y TTM69.23%Profit Margin-60.27%RSI (14)59.65Recom2.20
Dividend Gr. 3/5Y-Current Ratio10.69EPS Q/Q5.77%SMA205.78%Beta1.32Target Price19.86
Payout0.00%Debt/Eq0.03Sales Q/Q55.56%SMA5019.56%Rel Volume1.26Prev Close13.19
Employees352LT Debt/Eq0.02EarningsAug 04SMA200-24.83%Avg Volume991.50KPrice13.88
IPO DateJan 30, 2025Option/ShortYes / YesEPS/Sales Surpr.7.55% 3.70%Net Debt/EBITDA0.37Volume1,244,467Change5.23%
Analyst Ratings
DateActionAnalystRatingTarget
May-27-26ReiteratedGoldman SachsBuy$25 → $17
Feb-18-26ReiteratedLake StreetBuy$40 → $20
Feb-18-26ReiteratedRobert W. Baird$28 → $14
Feb-18-26ReiteratedStifel Nicolaus$25 → $22
Feb-08-26InitiatedUBSBuy$24
Feb-04-26ReiteratedStifel Nicolaus$31 → $25
Feb-02-26ReiteratedTruist Financial$37 → $25
Jan-26-26InitiatedTD CowenHold$17
Jan-15-26ReiteratedGoldman SachsBuy$33 → $25
Jan-09-26ReiteratedLake StreetBuy$35 → $40
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue11010065
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A474529
Gross Profit635636
Selling, General and Administrative Excl. Other1039255
Research and Development373526
Other Operating Expense000
Operating Income-77-72-45
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-11210
Net Income Before Taxes-66-73-55
Income Taxes
000
Consolidated Net Income-66-73-55
Net Income From Continuing Operations-66-73-55
Net Income-66-73-55
EPS (Recurring)-1.51-1.81-8.60
EPS (Basic, Before Extraordinaries)-1.51-1.81-8.60
EPS (Diluted)-1.51-1.81-8.60
EBITDA-64-70-54
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio5.5512.49—
Gross Margin57.2756.0055.38
Operating Margin-70.00-72.00-69.23
Net Margin-60.00-73.00-84.62
Shares Outstanding44416
Market Capitalization6111,249—
Operating Lease Expense
———
Insider Trading Volume
$15.60$14.65$13.69$12.73$11.78● Close Price0.00K221.96K443.93K665.89K887.85KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Jones ChristyDirectorJun 04 '26Sale14.002,81139,35427,400Jun 05 12:00 AM
Hopman MarkChief Commercial OfficerJun 04 '26Sale12.312753,385130,612Jun 05 12:00 AM
Feider StephenChief Financial OfficerJun 02 '26Sale12.616,67684,165166,053Jun 03 12:00 AM
Hopman MarkChief Commercial OfficerJun 02 '26Sale12.615,32967,183130,887Jun 03 12:00 AM
Russell Steven JonChief Medical OfficerJun 02 '26Sale12.614,22253,227173,849Jun 03 12:00 AM
Saint SeanPresident & CEOJun 02 '26Sale12.6116,872212,707420,937Jun 03 12:00 AM
Mensinger MikeChief Product OfficerJun 02 '26Sale12.614,37855,194184,415Jun 03 12:00 AM
Lezack AdamDirectorMay 22 '26Sale11.2199811,18827,399May 26 12:00 AM
Lezack AdamDirectorMay 21 '26Sale9.951,0009,95011,432May 26 12:00 AM
Jones ChristyDirectorMay 21 '26Sale9.951,99819,88013,246May 26 12:00 AM
Hopman MarkChief Commercial OfficerDec 04 '25Sale30.662,06163,192136,216Mar 16 12:00 AM
Russell Steven JonChief Medical OfficerDec 02 '25Sale29.341,02530,069178,071Mar 16 12:00 AM
Hopman MarkChief Commercial OfficerDec 02 '25Sale29.3485625,112138,277Mar 16 12:00 AM
Hopman MarkChief Commercial OfficerMar 04 '26Sale11.573534,084139,133Mar 05 12:00 AM
Saint SeanPresident & CEOMar 02 '26Sale12.363,38441,832437,809Mar 03 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR